Provided by Tiger Trade Technology Pte. Ltd.

FUSEN PHARM

0.800
+0.0405.26%
Volume:67.00K
Turnover:50.65K
Market Cap:591.20M
PE:-2.83
High:0.800
Open:0.760
Low:0.740
Close:0.760
52wk High:1.750
52wk Low:0.235
Shares:739.00M
HK Float Shares:739.00M
Volume Ratio:2.37
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.283
ROE:-40.49%
ROA:-2.47%
PB:1.54
PE(LYR):-2.83
PS:2.21

Loading ...

FUSEN PHARM (01652) Appoints Zhongzheng Tianheng as New Auditor

Stock News
·
Dec 24

Fusen Pharmaceutical Replaces Auditor After Fee Dispute

Reuters
·
Dec 24

FUSEN PHARM (01652): "Nicardipine Hydrochloride Injection" Generic Drug Application Approved for Market Launch

Stock News
·
Dec 12

Fusen Pharmaceutical - Approval Issued by Nmpa for Consistency Evaluation of Nicardipine Hydrochloride Injection

THOMSON REUTERS
·
Dec 12

Fusen Pharmaceutical Wins Regulatory Approval for Nicardipine Hydrochloride Injection in China

Reuters
·
Dec 12

Fusen Pharmaceutical (01652) Releases Monthly Return for November 2025

Bulletin Express
·
Dec 01

HK Stock Movement | FUSEN PHARM (01652) Surges Over 7% as Its "Azilsartan Potassium Tablets" Gain Market Approval

Stock News
·
Nov 17

Fusen Pharmaceutical's Unit Get China Nod for Marketing of Hypertension Drug

MT Newswires Live
·
Nov 14

Fusen Pharmaceutical - Approval From Nmpa

THOMSON REUTERS
·
Nov 14

Fusen Pharmaceutical Co Ltd - Measartan Potassium Tablets Approved for Marketing

THOMSON REUTERS
·
Nov 14

Further weakness as Fusen Pharmaceutical (HKG:1652) drops 12% this week, taking five-year losses to 85%

Simply Wall St.
·
Nov 09

Fusen Pharmaceutical (01652) Reports October 2025 Monthly Securities Movements

Bulletin Express
·
Nov 03

HK Stock Movement | FUSEN PHARM (01652) Surges Nearly 74% Intraday as Enzalutamide Soft Capsule Approved and Metformin Empagliflozin Tablet Included in National Bulk-Buy Program

Stock News
·
Oct 31

FUSEN PHARM (01652): "Enzalutamide Soft Capsule" Approved for Market Launch

Stock News
·
Oct 30

Fusen Pharmaceutical Wins Approval for Enzalutamide Soft Capsules in China

Reuters
·
Oct 30

BRIEF-Fusen Pharmaceutical Says Enzalutamide Soft Capsules Approved For Marketing by NMPA

Reuters
·
Oct 30

Fusen Pharmaceutical Co Ltd - Enzalutamide Soft Capsules Approved for Marketing

THOMSON REUTERS
·
Oct 30

Fusen Pharmaceutical - Approval From China's National Medical Products Administration

THOMSON REUTERS
·
Oct 30

Fusen Pharmaceutical (1652) Announces Selection in Eleventh Batch of National Centralised Medicines Procurement

Bulletin Express
·
Oct 30

FUSEN PHARM (01652): Metformin Empagliflozin Tablets (I) Shortlisted in China's 11th National Drug Centralized Procurement Bidding

Stock News
·
Oct 30